Display search results for ** instead (3558 products)

Showing 31-40 of 3558

06 Jul 2021  |  North America

Global Decentralized Clinical Trial (DCT) Growth Opportunities

Strategic Partnering and M&A Activity in At-home Monitoring Solutions Gain Momentum

Frost & Sullivan presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the markets maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations (...

USD 2,450.00
01 Jul 2021  |  North America

Global Computed Tomography Growth Opportunities

Increased Demand and Purchase Parameters on Multivariate Trends Propel Transformational Growth

An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing annually by 3%–4%. CT has become an indispensable tool in illness diagnosis and management, playing an instrumental role in COVID-19 management. The dynamic CT industry involves many participants introducing technological innovations frequently to ma...

USD 4,950.00
30 Jun 2021  |  North America

US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities

Telegenetic Counseling to Revolutionize Access to Patient Care

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

USD 2,450.00
29 Jun 2021  |  North America

Frost Radar™: Digital Operating Rooms, 2020

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Hospitals are under extreme pressure to reduce costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical issues entail finding new methods to reduce human error and improve the efficiency and quality of surgical care. Technology is now available to help hospitals reduce sur...

USD 4,950.00
28 Jun 2021  |  North America

Global Medical Imaging & Informatics Outlook, 2021

AI, Long-term Partnerships, and Cloud to Influence Growth Strategies

The global medical imaging and informatics market is experiencing dynamic changes with the emergence of advanced technologies, evolving clinical and administrative needs, and the introduction of new policies and regulations, which is forcing industry participants to innovate to maintain their competitive edge. Technologies such as artificial intell...

USD 4,950.00

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The innovations in this issue include a range of novel implantables such as an implantable cardiac monitor, an implantable device for fluid overload management, an implantable for canc...

USD 950.00
23 Jun 2021  |  Global

Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

USD 4,950.00
23 Jun 2021  |  Global

Global RNA Therapeutics:Technology Growth Opportunities

Advances in RNA Modifications, Formulation, and Stabilization to Drive Growth of RNA Therapeutics

RNA therapeutics is a rapidly expanding area of next-generation biological drugs. RNA is a versatile molecule and naturally regulates gene expression, either by upregulation or downregulation. This function is employed to design novel RNA therapeutics. The fundamentals of RNA therapeutics consists of delivering functional RNA at a target; however, ...

USD 4,950.00

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers innovations focused on stem cell therapy -- both allogeneic and autologous. A number of emerging technologies have been discussed for a variety of therapeutic indications including cancer, autoimmune diseases, and neurological disorders. Further, innovat...

USD 950.00
17 Jun 2021  |  North America

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...

USD 4,950.00

Showing 31-40 of 3558